Your Article Summary
See Latest ArticlesInvasive Inflammatory Myofibroblastic Tumor of the Lung
Journal of Thoracic Oncology, 06/26/09
Van Den Heuvel DA et al. - The authors present a case of pulmonary IMT in a 15-year-old male with malignant features on radiographic and 18F-Fluoro-deoxyglucose positron emission tomography imaging. Pathogenesis, pathology findings, clinical behavior, and imaging of pulmonary IMT are briefly discussed.
Related Articles
Inflammatory Myofibroblastic Tumors of the Abdomen as Mimickers of Malignancy: Imaging Features in Nine Children
American Journal of Roentgenology, 11/06/09
Relevance Score: 68%
Inflammatory myofibroblastic tumors in childhood
Cancer, 10/27/09
Relevance Score: 68%
Inflammatory myofibroblastic tumor of the conjunctiva: Response to chemotherapy with low-dose methotrexate and vinorelbine
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 67%
Inflammatory Myofibroblastic Tumor Presenting as a Large Mass and a Spontaneously Resolving Nodule in the Lung
Journal of Bronchology, 10/20/09
Relevance Score: 64%
Laryngeal inflammatory myofibroblastic tumors: Different clinical appearance and histomorphologic presentation of one entity
Head & Neck, 10/02/09
Relevance Score: 64%
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Quantitative Airway Assessment on Computed Tomography in Patients with alpha-1-antitrypsin Deficiency
COPD: Journal of Chronic Obstructive Pulmonary Disease, 12/09/09
The Use of Volumetric CT as an Imaging Biomarker in Lung Cancer
Academic Radiology, 12/08/09
HRCT Features of Small Peripheral Lung Carcinomas Detected in a Low-dose CT Screening Program
Academic Radiology, 12/08/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy
Anti-Cancer Drugs, 12/09/09
Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/09/09
Beta-Tubulin III mRNA expression and docetaxel sensitivity in non-small cell lung cancer
Clinical and Investigative Medicine, 12/09/09